Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Editorial [Hot Topic:Non-Receptor Tyrosine Kinases as Molecular Targets for Patient Tailored Cancer Therapy (Guest Editors: F.M. Uckun, A. Vassilev and H. Tibbles)]
pp. 593-593(1)
Authors: Uckun, Fatih M.; Vassilev, Alexei; Tibbles, Heather

Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy
pp. 594-611(18)
Authors: Gunby, Rosalind H.; Sala, Elisa; Tartari, Carmen J.; Puttini, Miriam; Gambacorti-Passerini, Carlo; Mologni, Luca

Targeting JAK3 Tyrosine Kinase-Linked Signal Transduction Pathways with Rationally-Designed Inhibitors
pp. 612-623(12)
Authors: Uckun, Fatih M.; Vassilev, Alexei; Dibirdik, Ilker; Tibbles, Heather

Bruton's Tyrosine Kinase as a New Therapeutic Target
pp. 624-632(9)
Authors: Uckun, Fatih M.; Tibbles, Heather E.; Vassilev, Alexei O.

Non-Receptor Tyrosine Kinase Inhibitors in Lung Cancer
pp. 633-642(10)
Authors: Hahn, Olwen; Salgia, Ravi

Jak2 Tyrosine Kinase and Cancer: How Good Cells Get HiJAKed
pp. 643-650(8)
Authors: Godeny, Michael D.; Sayeski, Peter P.

Src Family Nonreceptor Tyrosine Kinases as Molecular Targets for Cancer Therapy
pp. 651-659(9)
Authors: Johnson, Faye M.; Gallick, Gary E.

Synthetic Src-Kinase Domain Inhibitors and Their Structural Requirements
pp. 660-680(21)
Authors: Schenone, Silvia; Manetti, Fabrizio; Botta, Maurizio

Role of Focal Adhesion Kinase in Human Cancer: A Potential Target for Drug Discovery
pp. 681-684(4)
Authors: Han, Edward Kyu-Ho; McGonigal, Thomas

Synthesis and Structure-Activity Relationships of Potent Antitumor Active Quinoline and Naphthyridine Derivatives
pp. 685-709(25)
Authors: Srivastava, Sanjay K.; Jha, Amrita; Agarwal, Shiv K.; Mukherjee, Rama; Burman, Anand C.